Does Dr. AKPOBO AKPOROTU have financial conflicts of interest?

Dr. AKPOBO AKPOROTU (MD) has received a total of $1,855 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,855 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. AKPOBO AKPOROTU?

According to CMS Open Payments data, Dr. AKPOBO AKPOROTU received funding from ASTRAZENECA PHARMACEUTICALS ($478), BAYER HEALTHCARE PHARMACEUTICALS ($433), and OPKO PHARMACEUTICALS ($414).

Does Dr. AKPOBO AKPOROTU receive research grants or speaking fees?

Dr. AKPOBO AKPOROTU has received $1,855 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. AKPOBO AKPOROTU

MDReal-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: RIVERSIDE, CA 92503

NPI Number: 1396285698

LIFETIME INDUSTRY VALUE

$1,855

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AKPOROTU is a verified Internal Medicine, Nephrology practitioner based in RIVERSIDE, CA.

Between 2021 and 2024, Dr. AKPOROTU had an overall industry promotional and research financial footprint of $1,855 as recorded in the federal CMS Open Payments database.

$1,855 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AKPOROTU's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $478 (representing 25.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$478

25.8%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 2

$433

23.3%

OPKO PHARMACEUTICALS

Rank 3

$414

22.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.